Back to search

Article

Tyrosine kinase inhibitors in cancer treatment (Part II)

1998-12-01

Abstract excerpt

In the last few years, enormous progress in the field of signal transduction inhibition has been made. Many companies have entered the field. Along with the epidermal growth factor receptor (EGFR) tyrosine kinase, many other tyrosine kinases have been identified as interesting targets for drug discovery projects. X-ray data of more than 40 crystal structures of protein kinases, in most cases complexed with an inhi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e334e2c7-9530-5ec6-9bfd-40a4a0a0212d
DOI
10.1517/13543776.8.12.1599
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tyrosine kinase inhibitors in cancer treatment (Part II)DOI 10.1517/13543776.8.12.1599
Select a neighboring publication to make it the new centre.